•
Sep 30, 2018

Arrowhead Pharmaceuticals Q4 2018 Earnings Report

Total Revenue
$11.3M
Previous year: $8.71M
+29.2%
EPS
-$0.12
Previous year: -$0.15
-20.0%
Gross Profit
$11.3M
Previous year: $8.71M
+29.2%
Cash and Equivalents
$30.1M
Previous year: $24.8M
+21.3%
Free Cash Flow
-$3.39M
Previous year: -$9.31M
-63.6%
Total Assets
$112M
Previous year: $104M
+7.3%

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals